Suppr超能文献

曼月乐:只是一种避孕装置?还是一种具有多种临床应用的方式!

Mirena: Just a contraceptive device? or A modality with diverse clinical applications !

作者信息

Agarwal Neha, Chopra Seema

机构信息

Department of Obstetrics and Gynaecology, Maulana Azad Medical College, Lok Nayak Jai Prakash Hospital, New Delhi, India.

Department of Obstetrics and Gynaecology, Post Graduate Institute of Medical Education and Research, Chandigarh, India.

出版信息

J Family Med Prim Care. 2022 Sep;11(9):5031-5037. doi: 10.4103/jfmpc.jfmpc_2545_20. Epub 2022 Oct 14.

Abstract

Abnormal uterine bleeding is the most frequently encountered complaint of the reproductive-age women. Heavy menstrual blood loss is responsible for interfering with women's physical, emotional, social, and quality of life. Levonorgestrel-releasing intrauterine device (LNG-IUS) is a highly effective reversible form of contraception. Besides this, its role in the treatment of heavy menstrual bleeding (HMB), endometrial hyperplasia, early-stage endometrial cancers, and endometrial protection as a part of hormone replacement therapy (HRT) is very well studied. This review will revisit the role of LNG-IUS as a nonsurgical option in the management of HMB.

摘要

异常子宫出血是育龄期女性最常遇到的问题。月经过多会干扰女性的身体、情绪、社交及生活质量。左炔诺孕酮宫内节育器(LNG-IUS)是一种高效的可逆避孕方式。除此之外,其在治疗月经过多(HMB)、子宫内膜增生、早期子宫内膜癌以及作为激素替代疗法(HRT)一部分的子宫内膜保护方面的作用已得到充分研究。本综述将重新审视LNG-IUS作为非手术选择在HMB管理中的作用。

相似文献

1
Mirena: Just a contraceptive device? or A modality with diverse clinical applications !
J Family Med Prim Care. 2022 Sep;11(9):5031-5037. doi: 10.4103/jfmpc.jfmpc_2545_20. Epub 2022 Oct 14.
2
Progesterone or progestogen-releasing intrauterine systems for heavy menstrual bleeding.
Cochrane Database Syst Rev. 2015 Apr 30(4):CD002126. doi: 10.1002/14651858.CD002126.pub3.
3
Progesterone or progestogen-releasing intrauterine systems for heavy menstrual bleeding.
Cochrane Database Syst Rev. 2005 Oct 19(4):CD002126. doi: 10.1002/14651858.CD002126.pub2.
4
A risk-benefit assessment of the levonorgestrel-releasing intrauterine system.
Drug Saf. 1996 Dec;15(6):430-40. doi: 10.2165/00002018-199615060-00006.
6
Levonorgestrel intrauterine system for endometrial protection in women with breast cancer on adjuvant tamoxifen.
Cochrane Database Syst Rev. 2009 Oct 7(4):CD007245. doi: 10.1002/14651858.CD007245.pub2.
8
Levonorgestrel-releasing intrauterine system versus endometrial ablation for heavy menstrual bleeding.
Am J Obstet Gynecol. 2021 Feb;224(2):187.e1-187.e10. doi: 10.1016/j.ajog.2020.08.016. Epub 2020 Aug 12.
9
The levonorgestrel-releasing intrauterine system in heavy menstrual bleeding: a benefit-risk review.
Drugs. 2012 Jan 22;72(2):193-215. doi: 10.2165/11598960-000000000-00000.

本文引用的文献

2
Long-term efficacy and feasibility of levonorgestrel-releasing intrauterine device use in patients with adenomyosis.
Medicine (Baltimore). 2020 May 29;99(22):e20421. doi: 10.1097/MD.0000000000020421.
3
Treatment of symptomatic adenomyosis with the levonorgestrel-releasing intrauterine system.
Int J Gynaecol Obstet. 2019 Sep;146(3):357-363. doi: 10.1002/ijgo.12887. Epub 2019 Jun 27.
5
Cost-effectiveness of treatments for heavy menstrual bleeding.
Am J Obstet Gynecol. 2017 Nov;217(5):574.e1-574.e9. doi: 10.1016/j.ajog.2017.07.024. Epub 2017 Jul 25.
6
Treatment strategies for pelvic pain associated with adenomyosis.
Gynecol Endocrinol. 2016 Oct;32(sup2):19-22. doi: 10.1080/09513590.2016.1232673.
8
New WHO Classification of Endometrial Hyperplasias.
Geburtshilfe Frauenheilkd. 2015 Feb;75(2):135-136. doi: 10.1055/s-0034-1396256.
10
Trends of AUB in tertiary centre of Shimla hills.
J Midlife Health. 2013 Jan;4(1):67-8. doi: 10.4103/0976-7800.109648.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验